Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B0094ff49eb58e541ce820f23b2e2dd18> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B0094ff49eb58e541ce820f23b2e2dd18 NCIT_P378 "NCI" @default.
- B0094ff49eb58e541ce820f23b2e2dd18 type Axiom @default.
- B0094ff49eb58e541ce820f23b2e2dd18 annotatedProperty IAO_0000115 @default.
- B0094ff49eb58e541ce820f23b2e2dd18 annotatedSource NCIT_C173000 @default.
- B0094ff49eb58e541ce820f23b2e2dd18 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with taselisib in patients with tumors that have PIK3CA gene mutations but do not have KRAS mutations or PTEN inactivating mutations, excluding breast cancers and squamous cell lung cancers that have PIK3CA gene mutations or PIK3CA loss of function mutations." @default.